Dr. Reddy’s Signs License Deal for Once-Yearly Lenacapavir The Story:Dr. Reddy’s has signed a royalty-free, non-exclusive license agreement with Gilead Sciences for investigational once-yearly lenacap...
Key Highlights: Implications: Gland Pharma’s move to acquire Gland Pharma USA Inc. directly from its Singapore intermediate holding company is a purely internal restructuring that removes ...
